Clinical Trials Directory

Trials / Unknown

UnknownNCT01969630

Paclitaxel-eluting Balloon Angioplasty With Provisional Use of Nitinol Stent Versus Systematic Implantation of Paclitaxel-eluting Stent for the Treatment of Femoropopliteal de Novo Lesions

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
250 (estimated)
Sponsor
Ospedale San Donato · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

To determine in patients with symptomatic femoropopliteal lesions whether percutaneous revascularization with paclitaxel-eluting balloon angioplasty (PEB) and provisional nitinol stent is superior with respect to the 12-month incidence of restenosis compared to treatment with systematic paclitaxel-eluting stent (PES) angioplasty

Conditions

Interventions

TypeNameDescription
DEVICEPEBPaclitaxel eluting balloon angioplasty plus provisional nitinol stent implantation
DEVICEPESSystematic Paclitaxel eluting stent angioplasty

Timeline

Start date
2013-10-01
Primary completion
2015-10-01
First posted
2013-10-25
Last updated
2013-10-25

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT01969630. Inclusion in this directory is not an endorsement.

Paclitaxel-eluting Balloon Angioplasty With Provisional Use of Nitinol Stent Versus Systematic Implantation of Paclitaxe (NCT01969630) · Clinical Trials Directory